Diagnostic criteria for Parkinson disease

Archives of Neurology

Volumn 56, Issue 1, 1999, Pages 33-39

  Gelb, Douglas J ^a   Oliver, Eugene ^b   Gilman, Sid ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ARTICLE; AUTONOMIC DYSFUNCTION; BRADYKINESIA; CLINICAL EXAMINATION; CLINICAL PROTOCOL; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; DISEASE MARKER; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LEWY BODY; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RIGIDITY; TREMOR;

ANTIPARKINSON AGENTS; DIAGNOSTIC IMAGING; HUMANS; LEVODOPA; PARKINSON DISEASE; POSTURE; PROBABILITY; TREMOR;

EID: 0032937059     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.1.33     Document Type: Article

References (72)

1. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745-752.
2. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol. 1990;53:245-249.
3. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42:1142-1146.
4. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32(suppl):S125-S127.
5. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence Acta Neurol Scand. 1994;89:242-251.
6. Gibb WRG. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J. 1988;64:345-351.
7. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci. 1991;18:275-278.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
9. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol. 1993;60:595-599.
10. Jellinger KA. The neuropathologic diagnosis of secondary parkinsonian syndromes. Adv Neurol. 1996;69:293-303.
11. Hughes AJ, Ben-Schlomo Y, Daniel SE, Lees AJ. Diagnosis of PD [letter]. Neurology. 1993;43:1630.
12. Salisachs P, Findley LJ. Problems in the differential diagnosis of essential tremor. In: Findley LJ, Capildeo R, eds. Movement Disorders: Tremor. London, England: Macmillan: 1984:219-224.
13. Findley LJ. Tremors: differential diagnosis and pharmacology. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 2nd ed. Baltimore, Md: Williams & Wilkins; 1993:293-313.
14. Rajput AH. Clinical features of tremor in extrapyramidal syndromes. In: Findley LJ, Koller WC, eds. Handbook of Tremor Disorders. New York, NY: Marcel Dekker; 1995:275-291.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
16. Martin WE, Loewenson RB, Resch JA, Baker AB. Parkinson's disease: clinical analysis of 100 patients. Neurology. 1973;23:783-790.
17. Selby G. The Graeme Robertson memorial lecture, 1983: the long-term prognosis of Parkinson's disease. Clin Exp Neurol. 1984;20:1-25.
18. Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology. 1997;48:376-380.
19. Rajput AH, Rozdilsky B, Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology. 1991;41:1298-1299.
20. Wenning GK, Ben-Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry. 1995;58:160-166.
21. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson disease. Arch Neurol. 1995;52:294-298.
22. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997;54:937-944.
23. Collins SJ, Ahlskog JE, Parisi JE. Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry. 1995;58:167-173.
24. Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathologic spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain. 1995;118:759-770.
25. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain. 1989;112:1171-1192.
26. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology. 1990;40:1203-1212.
27. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA. Diffuse Lewy body disease and progressive dementia. Neurology. 1988;38:1520-1528.
28. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 1992;22:911-922.
29. Kuzuhara S, Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv Neurol. 1993;60:464-469.
30. Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Mov Disord. 1995;10:188-194.
31. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
32. Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases. Neurology. 1992;42:1323-1327.
33. Rajput AH, Rozdilsky B, Rajput A, Ang L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol. 1990;13:553-558.
34. Golbe LI, Davis PH. Progressive supranuclear palsy. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 2nd ed. Baltimore. Md: Williams & Wilkins; 1993:145-161.
35. Hughes AJ, Colosimo C, Kleedorfer B, Daniel SE, Lees AJ. The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1992;55:1009-1013.
36. Louis ED, Fahn S. Pathologically diagnosed diffuse Lewy body disease and Parkinson's disease: do the parkinsonian features differ? Adv Neurol. 1996;69:311-314.
37. Kluin KJ, Foster NL, Berent S, Gilman S. Perceptual analysis of speech disorders in progressive supranuclear palsy. Neurology. 1993;43:563-566.
38. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet. 1984;2:1262-1265.
39. Mortimer JA, Christensen KJ, Webster DD. Parkinsonian dementia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook or Clinical Neurology. Vol 46. Amsterdam, the Netherlands: Elsevier; 1985:371-384. Vinken PJ, Bruyn GW, Klawans HL, Frederiks JAM, eds. Neurobehavioural Disorders, Review Series 2.
40. Mortimer JA, Christensen KJ, Webster DD. Parkinsonian dementia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook or Clinical Neurology. Vol 46. Amsterdam, the Netherlands: Elsevier; 1985:371-384. Vinken PJ, Bruyn GW, Klawans HL, Frederiks JAM, eds. Neurobehavioural Disorders, Review Series 2.
41. Cummings JL. Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol. 1988;1:24-36.
42. Rajput AH. Prevalence of dementia in Parkinson's disease. In: Huber SJ, Cummings JL, eds. Parkinson's Disease: Neurobehavioral Aspects. New York, NY: Oxford University Press; 1992:119-131.
43. Mayeux R, Stern Y, Rosen J, Benson DF. Is "subcortical dementia" a recognizable clinical entity? Ann Neurol. 1983;14:278-283.
44. Whitehouse PJ. The concept of subcortical and cortical dementia: another look. Ann Neurol. 1986;19:1-6.
45. Cummings JL, ed. Subcortical Dementia. New York, NY: Oxford University Press: 1990.
46. Klatka LA, Schiffer RB, Powers JM, Kazee AM. Incorrect diagnosis ot Alzheimer's disease: a clinicopathologic study. Arch Neurol. 1996;53:35-42.
47. Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clin Neuropharmacol. 1990;13:36-47.
48. Mayeux R. The mental state in Parkinson's disease. In: Koller WC, ed. Handbook of Parkinson's Disease. 2nd ed. New York, NY: Marcel Dekker; 1992:159-184.
49. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease: a community-based study. Arch Neurol. 1996;53:175-179.
50. Cummings JL. Neuropsychiatric complications of drug treatment of Parkinson's disease. In: Huber SJ, Cummings JL, eds. Parkinson's Disease: Neurobehavioral Aspects. New York, NY: Oxford University Press: 1992:313-327.
51. Celesia GG, Wanamaker WM. Psychiatric disturbances in Parkinson's disease. Dis Nerv Syst. 1972;33:577-583.
52. Bell K, Dooneief G, Marder K, et al. Non-drug-induced psychosis in Parkinson's disease. Neurology. 1991;41(suppl 1):191.
53. Tanner CM, Goetz CG, Klawans HL. Autonomic nervous system disorders in Parkinson's disease. In: Koller WC, ed. Handbook of Parkinson's Disease. 2nd ed. New York, NY: Marcel Dekker; 1992:185-215.
54. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry. 1989(suppl):78-89.
55. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 1996;46:1470.
56. Martignoni E, Pacchetti C, Godi L, Micieli G, Nappi G. Autonomic disorders in Parkinson's disease. J Neural Transm. 1995;45(suppl):11-19.
57. Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson's disease. J Neurol Sci. 1972;15:251-265.
58. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35:420-426.
59. Tolosa E, Valldeoriola F, Marti MJ. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Suppl. 1994;42:15-31.
60. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996;46:922-930.
61. Goetz CG, Litvan I, Stebbins GT, et al. The accuracy of clinical signs in separating autopsy-proven corticobasal ganglionic degeneration from Parkinson's disease: positive and negative predictive value analysis [abstract]. Neurology. 1996;469(suppl):A260-A261.
62. Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin. 1992;10:405-420.
63. Brooks DJ. Neuroimaging of movement disorders. In: Watts RL, Koller WC, eds. Movement Disorders: Neurologic Principles and Practice New York. NY: McGraw-Hill Book Co: 1997:31-48.
64. Koller WC, Montgomery EB. Issues in the early diagnosis of Parkinson's disease. Neurology. 1997;49 (suppl 1):S10-S25.
65. Rajput AH, Jankovic J, McDermott M, and the Parkinson Study Group. Diagnostic accuracy in early Parkinson's disease [abstract]. Neurology. 1997;48:A369.
66. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015-2019.
67. Gibb WRG. The neuropathology of parkinsonian disorders. In: Jankovic J. Tolosa E, eds. Parkinson's Disease and Movement Disorders. 2nd ed. Baltimore. Md: Williams & Wilkins; 1993:253-270.
68. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol. 1996;55:259-272.
69. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology. 1997;48:126-132.
70. Hansen LA, Galasko D. Lewy body disease. Curr Opin Neurol Neurosurg. 1992;5:889-894.
71. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol. 1996;55:44-52.
72. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol. 1993;60:456-463.